HBV
  • Featured content
    At AASLD 2017, exciting new data were presented on both current and investigational therapies for chronic HBV infection.
    Date Posted: 11/30/2017
  • Featured content
    Listen to downloadable audio from a series of live Webinars by Stephen A. Harrison, MD, COL (Ret.), FAASLD; Paul Y. Kwo, MD; and Norah Terrault, MD, MPH, FAASLD, in which the clinical impact of new data reported at the Washington, DC meeting is discussed.
    Date Posted: 11/20/2017
  • Featured content
    In this downloadable slideset, expert faculty members Stephen A. Harrison, MD, COL (Ret.), FAASLD; Paul Y. Kwo, MD; and Norah Terrault, MD, MPH, FAASLD, summarize key studies from this important annual conference.
    Date Posted: 11/7/2017
  • Featured content
    Download this slideset to review key data and guidance on the latest treatment options for HBV infection.
    Date Posted: 10/10/2017
  • Featured content
    Led by Tram T. Tran, MD, a panel of experts discusses their approach to individualizing initial HCV therapy based on key disease and patient characteristics that have an impact on treatment choice, including HCV genotype, race, cirrhosis, comorbidities, and comedications.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 51 Shown
10 of 51 Shown
Show 10 More
Loading...